Skip to main content
Clinical Trials/NCT02007096
NCT02007096CompletedPhase 2

Transabdominal Plane (TAP) Blocks in Ventral Hernia Repair

Icahn School of Medicine at Mount Sinai1 site in 1 country127 target enrollmentStarted: August 2012Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
127
Locations
1
Primary Endpoint
Post-operative Opioid Use

Study Overview

Brief Summary

The purpose of this study is to determine if a Transabdominal Plane Block will decrease patient pain and pain medication use after a laparoscopic ventral (ventral, umbilical, incisional) hernia repair with mesh.

Detailed Description

Patients coming in for a laparoscopic ventral (ventral, umbilical, incisional) hernia repair with mesh are randomized to either receive a Transabdominal Plane Block injection or a placebo saline injection. The injection will be performed by surgeons under direct visualization during laparoscopic surgery prior to mesh placement. Patients will be followed up post-operatively and after hospital discharge to assess for opioid usage and pain score. Patients in both arms are medically cleared by the surgeon. Currently there are no studies that look at the use of Transabdominal Plane Block in ventral hernia repairs.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • age 18 and older
  • elective laparoscopic ventral (ventral, umbilical, incisional) hernia repair at Mount Sinai Hospital

Exclusion Criteria

  • age younger than 18
  • allergic reaction to bupivacaine
  • allergic reaction to opioids
  • opioid substance abuse

Arms & Interventions

Transabdominal Plane Block

Experimental

Receiving Transabdominal Plane Block with 0.25% bupivacaine

Intervention: Transabdominal Plane Block (Drug)

Non Transabdominal Plane Block

Placebo Comparator

Receiving placebo saline injection

Intervention: Non Transabdominal Plane Block (Drug)

Outcomes

Primary Outcomes

Post-operative Opioid Use

Time Frame: up to 24 hours

Amount of opioids used by patients at certain time points.

Secondary Outcomes

  • Operating Procedure Time(Procedure begin time to procedure end time)
  • Pain Score(24 hours postoperatively)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Celia M. Divino

Professor

Icahn School of Medicine at Mount Sinai

Study Sites (1)

Loading locations...

Similar Trials